147 related articles for article (PubMed ID: 38854001)
41. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy.
Matsuda N; Sato S; Shiba K; Okatsu K; Saisho K; Gautier CA; Sou YS; Saiki S; Kawajiri S; Sato F; Kimura M; Komatsu M; Hattori N; Tanaka K
J Cell Biol; 2010 Apr; 189(2):211-21. PubMed ID: 20404107
[TBL] [Abstract][Full Text] [Related]
42. Mitochondrial dysfunction in Parkinson's disease.
Hu Q; Wang G
Transl Neurodegener; 2016; 5():14. PubMed ID: 27453777
[TBL] [Abstract][Full Text] [Related]
43. Parkin and PINK1 functions in oxidative stress and neurodegeneration.
Barodia SK; Creed RB; Goldberg MS
Brain Res Bull; 2017 Jul; 133():51-59. PubMed ID: 28017782
[TBL] [Abstract][Full Text] [Related]
44. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
[TBL] [Abstract][Full Text] [Related]
45. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.
Quinn PMJ; Moreira PI; Ambrósio AF; Alves CH
Acta Neuropathol Commun; 2020 Nov; 8(1):189. PubMed ID: 33168089
[TBL] [Abstract][Full Text] [Related]
46. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
Dodson MW; Guo M
Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
[TBL] [Abstract][Full Text] [Related]
47. Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1/Parkin-mediated mitophagy.
Ma KY; Fokkens MR; Reggiori F; Mari M; Verbeek DS
Transl Neurodegener; 2021 Jun; 10(1):19. PubMed ID: 34127073
[TBL] [Abstract][Full Text] [Related]
48. DJ-1 is an essential downstream mediator in PINK1/parkin-dependent mitophagy.
Imberechts D; Kinnart I; Wauters F; Terbeek J; Manders L; Wierda K; Eggermont K; Madeiro RF; Sue C; Verfaillie C; Vandenberghe W
Brain; 2022 Dec; 145(12):4368-4384. PubMed ID: 36039535
[TBL] [Abstract][Full Text] [Related]
49. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism.
Borsche M; König IR; Delcambre S; Petrucci S; Balck A; Brüggemann N; Zimprich A; Wasner K; Pereira SL; Avenali M; Deuschle C; Badanjak K; Ghelfi J; Gasser T; Kasten M; Rosenstiel P; Lohmann K; Brockmann K; Valente EM; Youle RJ; Grünewald A; Klein C
Brain; 2020 Oct; 143(10):3041-3051. PubMed ID: 33029617
[TBL] [Abstract][Full Text] [Related]
50. Diverse Functions of Parkin in Midbrain Dopaminergic Neurons.
Song P; Krainc D
Mov Disord; 2024 Jun; ():. PubMed ID: 38858837
[TBL] [Abstract][Full Text] [Related]
51. Role of platelet in Parkinson's disease: Insights into pathophysiology & theranostic solutions.
Beura SK; Panigrahi AR; Yadav P; Singh SK
Ageing Res Rev; 2022 Sep; 80():101681. PubMed ID: 35798236
[TBL] [Abstract][Full Text] [Related]
52. Analysis of α-Synuclein Pathology in PINK1 Knockout Rat Brains.
Creed RB; Goldberg MS
Front Neurosci; 2018; 12():1034. PubMed ID: 30686993
[TBL] [Abstract][Full Text] [Related]
53. Parkin stabilizes PINK1 through direct interaction.
Shiba K; Arai T; Sato S; Kubo S; Ohba Y; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2009 Jun; 383(3):331-5. PubMed ID: 19358826
[TBL] [Abstract][Full Text] [Related]
54. Mutual Antagonism of PINK1/Parkin and PGC-1α Contributes to Maintenance of Mitochondrial Homeostasis in Rotenone-Induced Neurotoxicity.
Peng K; Xiao J; Yang L; Ye F; Cao J; Sai Y
Neurotox Res; 2019 Feb; 35(2):331-343. PubMed ID: 30242625
[TBL] [Abstract][Full Text] [Related]
55. Is Disrupted Mitophagy a Central Player to Parkinson's Disease Pathology?
Ko TK; Tan DJY
Cureus; 2023 Feb; 15(2):e35458. PubMed ID: 36860818
[TBL] [Abstract][Full Text] [Related]
56. The PINK1/Parkin pathway regulates mitochondrial morphology.
Poole AC; Thomas RE; Andrews LA; McBride HM; Whitworth AJ; Pallanck LJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1638-43. PubMed ID: 18230723
[TBL] [Abstract][Full Text] [Related]
57. Loss-of-function rodent models for parkin and PINK1.
Oliveras-Salvá M; Van Rompuy AS; Heeman B; Van den Haute C; Baekelandt V
J Parkinsons Dis; 2011; 1(3):229-51. PubMed ID: 23939304
[TBL] [Abstract][Full Text] [Related]
58. The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models.
Lee JJ; Andreazza S; Whitworth AJ
Sci Rep; 2020 Feb; 10(1):2693. PubMed ID: 32060339
[TBL] [Abstract][Full Text] [Related]
59. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin.
Whitworth AJ; Lee JR; Ho VM; Flick R; Chowdhury R; McQuibban GA
Dis Model Mech; 2008; 1(2-3):168-74; discussion 173. PubMed ID: 19048081
[TBL] [Abstract][Full Text] [Related]
60. Maackiain Ameliorates 6-Hydroxydopamine and
Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
